Clinical trial
Nicotinic Modulation of the Cognitive Control System in Late-life Depression
NCT04433767 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nicotinic Modulation of the Cognitive Control System in Late-life Depression
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 15, 2020
- Completion date
- October 7, 2022
- Enrollment
- 29 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.